PetVivo Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $27.79M
- P/E (TTM)
- –
- Dividend yield
- –
About PetVivo
Surgical & Medical Instruments & Apparatus, SIC 3841
PetVivo Holdings, Inc. is an emerging biomedical device company that manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead commercial product is Spryng with OsteoCushion Technology, an intra-articular injectable device composed of biocompatible, naturally derived collagen, elastin, and heparin particles designed to manage lameness and joint afflictions such as osteoarthritis in dogs and horses. The company also maintains a development pipeline of seventeen therapeutic devices targeted for veterinary and human applications. Customers consist of licensed veterinary practices, reached through wholesale distribution partners such as Vedco and Clipper, as well as direct-to-clinic and governmental accounts.
The company operates as a single business segment and maintains its corporate headquarters in Edina, Minnesota. Its manufacturing operations are conducted in an ISO 7 certified cleanroom facility located in Minneapolis, Minnesota. Products are commercialized and distributed across the United States.
Summary of the business section of PetVivo's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PetVivo Holdings, Inc.
- Founded
- 2009
- Headquarters
- Edina, MN
- Address
- 5251 Edina Industrial Blvd 55439
- Phone
- (952) 217-4952
- Employees
- 22, Mar 31, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- March 31
- Auditor
- Stephano Slack LLC, Wayne, Pennsylvania
Stock & identifiers
- Ticker
- PETV
- Exchange
- OTC
- Shares outstanding
- 38M, Aug 14, 2026
- Public float
- $12.13M, Jun 29, 2026
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-4 reverse, Feb 11, 2021; 1-for-4 reverse, Dec 30, 2020; 1-for-1.11 reverse, Nov 22, 2019; 1-for-500 reverse, Nov 14, 2014
- SEC CIK
- 1512922
- CUSIP
- 716817408
- ISIN
- US7168174081
- EIN
- 99-0363559
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| John Lai | Chief Executive Officer, Director | 4,795,076 |
| Garry N. Lowenthal | Chief Financial Officer | 1,075,131 |
| Robert James Rudelius | Director | 427,889 |
| Joshua David Ruben | Director | 53,832 |
| Joseph William Jasper | Director | 137,159 |
| Robert J. Costantino | Director | 109,661 |
| Diane M. Levitan | Director | 71,489 |
| John Spencer Breithaupt | Director | 60,187 |
| Michael Eugene Eldred | Director | 161,807 |
Employees
Headcount reported in annual reports
“As of June 29, 2026, we have 22 employees.”
Corporate history
Events identified from SEC filings